Effects of intravenous infusion of lidocaine in the sedation of patient in recovery after percutaneous nephrolithotomy surgery

Effects of intravenous infusion of lidocaine on the sedation of patient after percutaneous nephrolithotomy surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017011732017N1

Enrollment

Registered

2017-03-24

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary stone. Urinary bladder stone

Interventions

Intervention 1: Intervention group: Patients received an lidocaine IV infusion 1.5 mg/kg /h until the end of the operation. Intervention 2: Control group: Patients not received an lidocaine IV infusio

Treatment - Drugs

Intervention group: Patients received an lidocaine IV infusion 1.5 mg/kg /h until the end of the operation.

Control group: Patients not received an lidocaine IV infusion.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included: Patients under percutaneous nephrolithotomy surgery. Exclusion criteria included: Age less than 20 years and more than 60 years; ASAII and higher; sensitivity to lidocaine and kidney surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality of sedation. Timepoint: After treatment. Method of measurement: Based on Richmond Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahmudreza Mohaghegh

Iran University of Medical Sciences

Mohaghegh.mr@moheb.com+98 912 298 9628

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026